Increased morbidity and mortality in assisted conception cycles due to obstetric complications after the reintroduction of mixed oocyte.
The treatment of infertility and increased cost of assisted conception (AC) treatment has led to the use of non-dominant, polycystic ovarian syndrome (PCOS), and anovulation. Mixed embryo transfer (MET), which uses androgenic hormone, is the only policy that has seen an increase in oocyte donation and thus needs to be scientifically studied before its reintrodu 66cf4387b8
Sie müssen Mitglied von Korsika sein, um Kommentare hinzuzufügen!
Mitglied werden Korsika